Table 4.

Baseline characteristics (median (IQR)) of women with decline in eGFR ≥10 ml/min/1.73 m2 at follow-up

	No eGFR decline (n = 170)	eGFR decline (n = 27)	p-value
Age	33 (28–37)	31 (27–35)	0.20
Onset (d)	258 (240–272)	261 (241–273)	0.64
Early onset	21.8% (36/165)	18.5% (5/27)	0.70
Nulliparous	75.7% (128/169)	66.7% (18/27)	0.32
Time to f/u (d)	180 (152–190)	179 (154–190)	0.93
MD	15.3% (26/170)	3.7% (1/27)	0.10
IVF	7.7% (13/170)	0% (0/27)	0.14
GD	8.8% (15/170)	14.8% (4/27)	0.33
HELLP	21.2% (36/170)	18.5% (5/27)	0.75
Severe PE	70% (119/170)	48.2% (13/27)	0.03
AKI	10.1% (17/169)	0% (0/27)	0.09

HT Hypertension, BP Blood pressure in mmHg, PE Preeclampsia, AKI Acute kidney injury, GD gestational diabetes, f/u follow-up; d days